ReviewJournal of Huntington's disease2015
Indoleamine 2,3 Dioxygenase as a Potential Therapeutic Target in Huntington's Disease.
Gelareh Mazarei et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
27 papers cite it
this papercites it